Skip navigation

Canlyniadau chwilio am the care act 2014

Yn dangos 136 i 150 o 377 canlyniadau

HCPC responds to inquiry on contracts for PPE

HCPC this week submitted evidence to the Public Accounts Committee’s inquiry: Covid-19: Government procurement, and contracts for PPE.

August Bank Holiday Weekend 2021 - Service availability and how to contact us

Information about the areas operating urgent support, and how you can contact us if your query falls into one of these.

Physiotherapists: how to rejoin the Register if you’ve been removed

We want to get you back on the Register as soon as possible. Please follow these steps to make sure you've reapplied correctly. 

New legislation expands the number of professions able to issue fit notes

The UK government has introduced new legislation to allow a wider range of healthcare professionals to certify fit notes.

Clinical scientists, prosthetists/orthotists and speech and language therapists renewals - window closing soon

The deadline for clinical scientists, prosthetists/orthotists and speech and language therapists to complete their registration renewal is fast approaching

The HCPC responds to NHS England’s culture review of ambulance trusts

Andrew Smith, Deputy Chief Executive of the HCPC, comments on NHS England’s culture review of ambulance trusts.

Visitors – documentary submissions are becoming electronic only

As part of the changes to our approval process, education providers will make electronic-only documentary submissions from September 2019

Advertising Botox injections on social media

As a prescription-only medicine, it is unlawful for Botox or Botox treatments to be advertised in any way to the public

New Equality, Diversity and Inclusion plan approved by Council

A bold new action plan setting out the ways in which HCPC will deliver on our commitments to equality, diversity and inclusion (EDI) has been approved by the HCPC’s Council.

Joint statement on meeting regulatory standards during periods of global or national shortage of medicines

We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).

Top